Naicker, Dshanta Dyanedi.Werner, Lise.Kormuth, Emil.Passmore, Jo-Ann Shelley.Mlisana, Koleka Patience.Abdool Karim, Salim Safurdeen.Ndung'u, Peter Thumbi.2012-11-142012-11-1420082008Naicker D.D., Werner L., Kormuth E., et al. 2009. Interleukin-10 promoter polymorphisms influence HIV-1 susceptibility and primary HIV-1 pathogenesis. J Infect Dis 200, pp.448–452.1537-6613http://dx.doi.org/10.1086/600072http://hdl.handle.net/10413/7846Interleukin (IL)–10 directly inhibits human immunodeficiency virus type 1 (HIV-1) replication, but it may also promote viral persistence by inactivation of effector immune mechanisms. Here, we show in an African cohort that individuals with genotypes associated with high IL-10 production at 2 promoter single-nucleotide polymorphisms ( 1082 and 592) were less likely to become HIV-1 infected but had significantly higher median plasma viral loads during the acute phase ( 3 months after infection). However, as the infection progressed, the association between genotype and median viral load was reversed. Thus, IL-10 may influence HIV-1 susceptibility and pathogenesis, but effects on the latter may differ according to the infection phase.enInterleukin-10.HIV infections--Genetic aspects.Interleukin-10 Promoter Polymorphisms Influence HIV-1 Susceptibility and Primary HIV-1 Pathogenesis.Peer reviewed journal article